Finding:

1. close

   Lintuzumab

   Lintuzumab is a humanized monoclonal antibody used to treat cancer.
2. close

   Trastuzumab

   Trastuzumab has had a "major impact in the treatment of HER2-positive metastatic breast cancer". ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan, Clivatuzumab tetraxetan, Dacetuzumab, Elotuzumab, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab
3. close

   Bevacizumab

   It is used in the treatment of cancer, where it inhibits tumor growth by blocking the formation of new blood vessels (angiogenesis). ... Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Dacetuzumab, Elotuzumab, Etaracizumab, Etaratuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab, Nimotuzumab, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Trastuzumab, Tucotuzumab celmoleukin
4. close

   Natalizumab

   "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan*, Clivatuzumab tetraxetan*, Dacetuzumab, Elotuzumab†, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab†, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan*, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab
5. close

   Nimotuzumab

   Nimotuzumab is a humanized monoclonal antibody used to treat cancer. ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan*, Clivatuzumab tetraxetan*, Dacetuzumab, Elotuzumab†, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab†, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan*, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab
6. close

   Alemtuzumab

   Alemtuzumab (marketed as Campath, MabCampath or Campath-1H) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma. ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan, Clivatuzumab tetraxetan, Dacetuzumab, Elotuzumab, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab
7. close

   Tucotuzumab celmoleukin

   Tucotuzumab celmoleukin is a humanized monoclonal antibody used to treat cancer. ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan*, Clivatuzumab tetraxetan*, Dacetuzumab, Elotuzumab†, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab†, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan*, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab
8. close

   Dacetuzumab

   Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody used in the treatment of CD40-positive cancers. ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, Cantuzumab mertansine, Citatuzumab bogatox, Claretuzumab tetraxetan*, Clivatuzumab tetraxetan*, Dacetuzumab, Elotuzumab†, Etaracizumab, Farletuzumab, Gemtuzumab ozogamicin, Inotuzumab ozogamicin, Labetuzumab, Lintuzumab, Matuzumab†, Milatuzumab, Nimotuzumab, Pamtuzumab tetraxetan*, Pertuzumab, Sibrotuzumab, Sontuzumab, Tacatuzumab tetraxetan, Tigatuzumab, Trastuzumab, Tucotuzumab celmoleukin, Veltuzumab

Explore the following pages on Powerset:

• Lintuzumab,
• Trastuzumab,
• Bevacizumab,
• Natalizumab,
• Nimotuzumab,
• Alemtuzumab,
• Tucotuzumab celmoleukin,
• Dacetuzumab